课题基金 / 基金详情

Mechanisms of a Novel Combined Immunodeficiency Caused by a Homozygous Mutation in COPG1

Mechanisms of a Novel Combined Immunodeficiency Caused by a Homozygous Mutation in COPG1
COPG1 纯合突变引起的新型联合免疫缺陷的机制
批准号:
10493663
负责人:
RAIF SALIM GEHA
金额:
$5.27万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-05-03 至 2024-04-30

项目摘要

项目成果

RAIF SALIM GEHA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We identified a biallelic K652E mutation in the γ1-COP subunit of the heptameric coat protein I (COPI) complex in 5 Omani siblings, suffering from recurrent pulmonary infections with encapsulated bacteria, CMV and EBV viremia. The four older siblings presented with severe CD4+ T cell lymphopenia and increased T cell apoptosis; the youngest had normal T cell numbers shortly after birth, but developed CMV viremia and CD4+ T cell lymphopenia at 6 mo. Coat proteins deform membranes to generate transport vesicles. They also bind to cargo proteins to properly sort them into these vesicles, and ensure their transport to specific intracellular compartments. In the early secretory system, the COPII complex transports cargo from the endoplasmic reticulum (ER) to the Golgi, while the COPI complex transports select cargo in the other direction, from the Golgi to the ER, and additionally mediates CDC42-dependent transport through the Golgi. Specific sequences on cargo proteins recognized by COPI include the di-lysine and the di-arginine motifs. Coat proteins can also bind indirectly to COPI through transmembrane proteins that act as cargo receptors. These include the KDEL receptor (KDELR), which links COPI (residing on the cytosolic side of Golgi membrane) to soluble proteins within the Golgi (lumenal side) that have a KDEL sequence. KDEL proteins are abundant ER proteins involved in protein folding (chaperones). A fraction of KDEL proteins leak from the ER, and are retrieved from the Golgi to the ER through the KDELR and COPI. Defect in this retrieval leads to the loss of ER chaperones, which has been found to induce ER stress. Preliminary data show that fibroblasts from patients, and mice homozygous for the K652E γ1-COP mutation, express the mutant protein, but demonstrate defective COPI-mediated trafficking, and that the mutation disrupts the binding of the mutant COPI complex to KDELR. Mutant mice have severe hypogammaglobulinemia and poor antibody responses. Their B cells had increased ER stress and impaired immunoglobulin (Ig) secretion that was rescued by the ER stress inhibitor TUDCA. T cells from the mutant were normal in numbers, but had increased ER stress, and displayed increased apoptosis and diminished IL-4 production following sustained activation in vitro. We propose to test the hypothesis that the γ1-COP mutation disrupts COPI-mediated trafficking causing increased ER stress that impairs B and T cell function, increases susceptibility to bacterial and viral infection, and results in CD4+ T cell lymphopenia secondary to persistent viral infection. The studies proposed will elucidate the mechanisms by which a novel monogenic defect that impairs COPI-mediated trafficking leads to CID with CD4+ T cell lymphopenia, and will test pre-clinically the therapeutic efficacy of ER stress relieving drugs in this disease.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.jaci.2021.06.024
发表时间: 2021-09
期刊: The Journal of allergy and clinical immunology
影响因子: --
作者: [Chou J, Platt CD, Habiballah S, Nguyen AA, Elkins M, Weeks S, Peters Z, Day-Lewis M, Novak T, Armant M, Williams L, Rockowitz S, Sliz P, Williams DA, Randolph AG, Geha RS, Taking on COVID-19 Together Study Investigators]
通讯作者: Taking on COVID-19 Together Study Investigators
Rethinking newborn screening for severe combined immunodeficiency: Lessons from an international partnership for patients with primary immunodeficiencies in Pakistan.
重新思考新生儿严重联合免疫缺陷筛查:巴基斯坦原发性免疫缺陷患者国际合作伙伴关系的经验教训。
DOI: 10.1016/j.clim.2019.03.004
发表时间: 2019
期刊: Clinical immunology (Orlando, Fla.)
影响因子: --
作者: [Wallace,JacquelineG, Tipu,HamidNawaz, Stafstrom,Kelsey, Alosaimi,MohammedF, Massaad,MichelJ, Bainter,Wayne, Geha,RaifS, Chou,Janet]
通讯作者: Chou,Janet
DOI: 10.1126/sciimmunol.abf6723
发表时间: 2021-09-17
期刊: Science immunology
影响因子: 24.8
作者: [Bainter W, Lougaris V, Wallace JG, Badran Y, Hoyos-Bachiloglu R, Peters Z, Wilkie H, Das M, Janssen E, Beano A, Farhat KB, Kam C, Bercich L, Incardona P, Villanacci V, Bondioni MP, Meini A, Baronio M, Abarzua P, Parolini S, Tabellini G, Maio S, Schmidt B, Goldsmith JD, Murphy G, Hollander G, Plebani A, Chou J, Geha RS]
通讯作者: Geha RS
DOI: 10.1016/j.jaci.2020.08.022
发表时间: 2021-03
期刊: The Journal of allergy and clinical immunology
影响因子: --
作者: [Platt CD, Zaman F, Bainter W, Stafstrom K, Almutairi A, Reigle M, Weeks S, Geha RS, Chou J, International Consortium for Immunodeficiencies]
通讯作者: International Consortium for Immunodeficiencies
10
    Mechanisms of enhanced food allergy by S. aureus skin colonization in Atopic Dermatitis
    • 批准号:
      10638821
    • 项目类别:
    • 资助金额:
      $80.01万
    • 财政年份:
      2023
    • 负责人:
      RAIF SALIM GEHA
    • 依托单位:
    Molecular and cellular mechanisms in food anaphylaxis
    • 批准号:
      10408011
    • 项目类别:
    • 资助金额:
      $54.8万
    • 财政年份:
      2020
    • 负责人:
      RAIF SALIM GEHA
    • 依托单位:
    Mechanisms of a Novel Combined Immunodeficiency Caused by a Homozygous Mutation in COPG1
    • 批准号:
      10265627
    • 项目类别:
    • 资助金额:
      $44.25万
    • 财政年份:
      2020
    • 负责人:
      RAIF SALIM GEHA
    • 依托单位:
    Molecular and cellular mechanisms in food anaphylaxis
    • 批准号:
      10030396
    • 项目类别:
    • 资助金额:
      $54.8万
    • 财政年份:
      2020
    • 负责人:
      RAIF SALIM GEHA
    • 依托单位:
    国内基金
    海外基金
    补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
    靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
    • 批准号:
      JCZRQN202500010
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位:
    对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
    • 批准号:
      2025JJ70209
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      雷芬芳
    • 依托单位:
    AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      万荣
    • 依托单位: